BPG is committed to discovery and dissemination of knowledge
High Impact Articles
High impact papers are those to which special attention is paid by experts in the given field, with a large number of visitors, frequent downloads and higher citation rates. The research must be creative, with high academic standards and have a wide influence, if it is to become a high impact paper. They are ranked by the number of downloads.
Rank Full Article
1
Role of mitogen- and stress-activated kinases in inflammatory arthritis  
Sylvain G Bourgoin, Weili Hui
World J Pharmacol 4(4):265-273. Published online Dec 9, 2015. doi: 10.5497/wjp.v4.i4.265
2
Therapeutic targets and delivery challenges for Alzheimer’s disease  
Preshita Desai, Harshad Shete, Rahul Adnaik, John Disouza, Vandana Patravale
World J Pharmacol 4(3):236-264. Published online Sep 9, 2015. doi: 10.5497/wjp.v4.i3.236
3
Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement  
María L Cuestas, José R Oubiña, Verónica L Mathet
World J Pharmacol 4(1):96-116. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.96
4
Ocular drug delivery systems: An overview  
Ashaben Patel, Kishore Cholkar, Vibhuti Agrahari, Ashim K Mitra
World J Pharmacol 2(2):47-64. Published online Jun 9, 2013. doi: 10.5497/wjp.v2.i2.47
5
Role of opioid receptor heterodimerization in pain modulation and tolerance development  
Annu Mudgal, Santosh Pasha
World J Pharmacol 4(1):144-159. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.144
6
Non-selective beta-blockers in cirrhosis: Current concepts and controversies  
Neil Rajoriya, Dhiraj Tripathi
World J Pharmacol 5(1):15-31. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.15
7
Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?  
Pamela J Weathers, Melissa Towler, Ahmed Hassanali, Pierre Lutgen, Patrick Ogwang Engeu
World J Pharmacol 3(4):39-55. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.39
8
Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer  
Juliana Felgueiras, Margarida Fardilha
World J Pharmacol 3(4):120-139. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.120
9
Appropriate prescribing in the elderly: Current perspectives  
Amanda Hanora Lavan, John O’Grady, Paul Francis Gallagher
World J Pharmacol 4(2):193-209. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.193
10
Chemoprevention of gastrointestinal cancers by natural honey  
Mohamed MM Abdel-Latif
World J Pharmacol 4(1):160-167. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.160
11
Progress in pancreatic cancer therapeutics: The potential to exploit molecular targets  
Kiruthikah Thillai, Debashis Sarker, Paul Ross
World J Pharmacol 4(2):180-192. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.180
12
Novel strategies for the treatment of diabetic macular edema  
Hoang M Trinh, Mary Joseph, Kishore Cholkar, Dhananjay Pal, Ashim K Mitra
World J Pharmacol 5(1):1-14. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.1
13
Drug-transporter interaction testing in drug discovery and development  
Peter Krajcsi
World J Pharmacol 2(1):35-46. Published online Mar 9, 2013. doi: 10.5497/wjp.v2.i1.35
14
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?  
Serena Mazzucchelli, Marta Truffi, Luisa Fiandra, Luca Sorrentino, Fabio Corsi
World J Pharmacol 3(4):72-85. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.72
15
Carbapenemases: A worldwide threat to antimicrobial therapy  
José Miguel Sahuquillo-Arce, Alicia Hernández-Cabezas, Fernanda Yarad-Auad, Elisa Ibáñez-Martínez, Patricia Falomir-Salcedo, Alba Ruiz-Gaitán
World J Pharmacol 4(1):75-95. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.75
16
Pharmacological management of neuropathic pain in patients with vestibular schwannomas: Experience of the Atlantic Lateral Skull Base Clinic  
Andrea LO Hebb, Jana Sawynok, Manohar Bance, Simon Walling, Ken Chisholm, David P Morris
World J Pharmacol 3(2):24-32. Published online Jun 9, 2014. doi: 10.5497/wjp.v3.i2.24
17
Pharmacophore approaches in protein kinase inhibitors design  
Sergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, Andriy G Golub, Sergiy M Yarmoluk
World J Pharmacol 3(4):162-173. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.162
18
Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome  
Asfandyar Khan, Adam B Murphy
World J Pharmacol 4(1):1-16. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.1
19
Overview on metabolomics in traditional Chinese medicine  
Shi Qiu, Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Xi-Jun Wang
World J Pharmacol 3(3):33-38. Published online Sep 9, 2014. doi: 10.5497/wjp.v3.i3.33
20
Drug therapy for Parkinson’s disease: An update  
Omar ME Abdel-Salam
World J Pharmacol 4(1):117-143. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.117
21
Perspective of antiviral therapeutics for hepatitis C after liver transplantation  
Cheng-Maw Ho, Rey-Heng Hu, Po-Huang Lee
World J Pharmacol 3(4):193-198. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.193
22
Arsenic exposure decreases rhythmic contractions of vascular tone through sodium transporters and K+ channels  
Javier Palacios, Chukwuemeka R Nwokocha, Fredi Cifuentes
World J Pharmacol 3(2):18-23. Published online Jun 9, 2014. doi: 10.5497/wjp.v3.i2.18
23
Implantable (Bio)sensors as new tools for wireless monitoring of brain neurochemistry in real time  
Donatella Farina, Maria D Alvau, Giulia Puggioni, Giammario Calia, Gianfranco Bazzu, Rossana Migheli, Ottavio Sechi, Gaia Rocchitta, Maria S Desole, Pier Andrea Serra
World J Pharmacol 3(1):1-17. Published online Mar 9, 2014. doi: 10.5497/wjp.v3.i1.1
24
Importance of microenvironment in preclinical models of breast and prostate cancer  
Maija Valta, Katja Fagerlund, Mari Suominen, Jussi Halleen, Johanna Tuomela
World J Pharmacol 4(1):47-57. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.47
25
Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease  
Anne-Laure Pelletier, Pascale Nicaise-Roland
World J Pharmacol 5(1):44-50. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.44
26
Therapeutic options and vaccine development in the treatment of leishmaniasis  
Jill E Weatherhead, Laila Woc-Colburn
World J Pharmacol 4(2):210-218. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.210
27
Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders  
Libia Vega, Guillermo Elizondo
World J Pharmacol 2(4):107-114. Published online Dec 9, 2013. doi: 10.5497/wjp.v2.i4.107
28
Improving cancer therapy by targeting cancer stem cells: Directions, challenges, and clinical results  
Pier Adelchi Ruffini, Valentina Vaja, Marcello Allegretti
World J Pharmacol 4(1):58-74. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.58
29
Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia  
Shaun Hopper, Madhara Udawela, Elizabeth Scarr, Brian Dean
World J Pharmacol 5(1):32-43. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.32
30
Asthma in pregnancy  
Hayley K Blackburn, Douglas R Allington, Kendra A Procacci, Michael P Rivey
World J Pharmacol 3(4):56-71. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.56
31
Innovate combination of sevoflurane dilution in dimethyl sulfoxide: A stability study by gas chromatography and nuclear magnetic resonance  
F Dámaso Fernández-Ginés, Sergio García-Muñoz, Héctor Mateo-Carrasco, Miguel Ángel Rincón-Cervera, Manuel Cortiñas-Sáenz, José Antonio Morales-Molina, Carmen Fernández-Sánchez, Juan Miguel Expósito-López, Ignacio Rodríguez-García
World J Pharmacology 5(3):59-67. Published online Sep 9, 2016. doi: 10.5497/wjp.v5.i3.59
32
Quinolone-based first, second and third-line therapies for Helicobacter pylori  
Enzo Ierardi, Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Alfredo Di Leo
World J Pharmacol 4(4):274-280. Published online Dec 9, 2015. doi: 10.5497/wjp.v4.i4.274
33
Use of eltrombopag in thrombocytopenia of liver disease  
Vishal Sharma
World J Pharmacol 3(4):186-192. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.186
34
Long-term potentiation in autonomic ganglia: Potential role in cardiovascular disorders  
Karim A Alkadhi
World J Pharmacol 5(2):51-58. Published online Jun 9, 2016. doi: 10.5497/wjp.v5.i2.51
35
Emerging pharmacological strategies for the treatment of fibromyalgia  
Kim Lawson
World J Pharmacology 6(1):1-10. Published online Mar 9, 2017. doi: 10.5497/wjp.v6.i1.1
36
Telomerase activity: An attractive target for cancer therapeutics  
Lucia Picariello, Cecilia Grappone, Simone Polvani, Andrea Galli
World J Pharmacol 3(4):86-96. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.86
37
Antimicrobial resistance in clinically important biofilms  
Fatemeh Rafii, Mark E Hart
World J Pharmacol 4(1):31-46. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.31
38
Patents on antivirulence therapies  
María López, Beathriz Barbosa, Eva Gato, Germán Bou, María Tomás
World J Pharmacol 3(4):97-109. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.97
39
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned  
Ioannis S Vizirianakis
World J Pharmacol 3(4):110-119. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.110
40
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding  
Hilai Ahmadzai, Lisa BG Tee, Andrew Crowe
World J Pharmacol 3(4):153-161. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.153
41
Challenges and opportunities in the treatment of ulcerative colitis  
Sunil Ashokrao Nirmal, Sunil Shivaji Gangurde, Pratiksha Shankar Dumbre, Subodh Chandra Pal, Subhash Chandra Mandal
World J Pharmacol 4(2):219-226. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.219
42
Levomilnacipran and vortioxetine: Review of new pharmacotherapies for major depressive disorder  
Mei T Liu, Megan E Maroney, Evelyn R Hermes-DeSantis
World J Pharmacol 4(1):17-30. Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.17
43
Enhanced permeability and retention effect based nanomedicine, a solution for cancer  
Jun Fang
World J Pharmacol 4(2):168-171. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.168
44
Inhibitory effects of apigenin and kaempferol on the essential solute carrier transporters  
Ting Chan, Zhen Li, Jian Zheng, Florence Shin Gee Cheung, Ling Zhu, Fanfan Zhou
World J Pharmacol 2(4):115-121. Published online Dec 9, 2013. doi: 10.5497/wjp.v2.i4.115
45
Roles of cholinergic receptors during attentional modulation of cue detection  
Joshua A Burk
World J Pharmacol 2(4):84-91. Published online Dec 9, 2013. doi: 10.5497/wjp.v2.i4.84
46
Potential ability of xanthophylls to prevent obesity-associated cancer  
Masaru Terasaki, Michihiro Mutoh, Gen Fujii, Mami Takahashi, Rikako Ishigamori, Sonoko Masuda
World J Pharmacol 3(4):140-152. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.140
47
Role of antipsychotics for treating behavioral and psychological symptoms of dementia  
Kai Zhen Yap, Sui Yung Chan
World J Pharmacol 3(4):174-185. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.174
48
Protective effect of fu-qi granule on carbon tetrachloride-induced liver fibrosis in rats  
Lin Zhong, Yan-Ling Sun, Wen-Li Shi, Xiao Ma, Zhe Chen, Jia-Bo Wang, Rui-Sheng Li, Xue-Ai Song, Hong-Hong Liu, Yan-Ling Zhao, Xiao-He Xiao
World J Pharmacol 4(2):227-235. Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.227
49
Vitamin D and bone fracture healing  
Marks Ray
World J Pharmacol 3(4):199-208. Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.199
50
How and why chemicals from tobacco smoke can induce a rise in blood pressure  
Aurelio Leone
World J Pharmacol 1(1):10-20. Published online Feb 9, 2012. doi: 10.5497/wjp.v1.i1.10